188 related articles for article (PubMed ID: 24275691)
1. Neutrophils and type 1 autoimmune diabetes.
Battaglia M
Curr Opin Hematol; 2014 Jan; 21(1):8-15. PubMed ID: 24275691
[TBL] [Abstract][Full Text] [Related]
2. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes.
Wang Y; Xiao Y; Zhong L; Ye D; Zhang J; Tu Y; Bornstein SR; Zhou Z; Lam KS; Xu A
Diabetes; 2014 Dec; 63(12):4239-48. PubMed ID: 25092677
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity in type 1 diabetes.
Diana J; Gahzarian L; Simoni Y; Lehuen A
Discov Med; 2011 Jun; 11(61):513-20. PubMed ID: 21712017
[TBL] [Abstract][Full Text] [Related]
4. Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.
Serreze DV; Chen YG
Trends Immunol; 2005 Nov; 26(11):603-7. PubMed ID: 16140038
[TBL] [Abstract][Full Text] [Related]
5. Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery.
Planas R; Pujol-Borrell R; Vives-Pi M
Immunol Lett; 2010 Oct; 133(2):55-61. PubMed ID: 20708640
[TBL] [Abstract][Full Text] [Related]
6. The putative role of proteolytic pathways in the pathogenesis of Type 1 diabetes mellitus: the 'autophagy' hypothesis.
Fierabracci A
Med Hypotheses; 2014 May; 82(5):553-7. PubMed ID: 24582332
[TBL] [Abstract][Full Text] [Related]
7. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
8. Role of innate immunity in triggering and tuning of autoimmune diabetes.
Kim HS; Lee MS
Curr Mol Med; 2009 Feb; 9(1):30-44. PubMed ID: 19199940
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease.
Skog O; Korsgren S; Melhus A; Korsgren O
Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):118-23. PubMed ID: 23422243
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
[TBL] [Abstract][Full Text] [Related]
11. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
[TBL] [Abstract][Full Text] [Related]
12. Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes.
Vecchio F; Lo Buono N; Stabilini A; Nigi L; Dufort MJ; Geyer S; Rancoita PM; Cugnata F; Mandelli A; Valle A; Leete P; Mancarella F; Linsley PS; Krogvold L; Herold KC; Elding Larsson H; Richardson SJ; Morgan NG; Dahl-Jørgensen K; Sebastiani G; Dotta F; Bosi E; ; ; Battaglia M
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232284
[TBL] [Abstract][Full Text] [Related]
13. Neutrophils and type 1 diabetes: current knowledge and suggested future directions.
Battaglia M; Petrelli A; Vecchio F
Curr Opin Endocrinol Diabetes Obes; 2019 Aug; 26(4):201-206. PubMed ID: 31157631
[TBL] [Abstract][Full Text] [Related]
14. Reduction of circulating neutrophils precedes and accompanies type 1 diabetes.
Valle A; Giamporcaro GM; Scavini M; Stabilini A; Grogan P; Bianconi E; Sebastiani G; Masini M; Maugeri N; Porretti L; Bonfanti R; Meschi F; De Pellegrin M; Lesma A; Rossini S; Piemonti L; Marchetti P; Dotta F; Bosi E; Battaglia M
Diabetes; 2013 Jun; 62(6):2072-7. PubMed ID: 23349491
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
[TBL] [Abstract][Full Text] [Related]
16. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
Boitard C
Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
[TBL] [Abstract][Full Text] [Related]
17. The role of interferon alpha in initiation of type I diabetes in the NOD mouse.
Li Q; McDevitt HO
Clin Immunol; 2011 Jul; 140(1):3-7. PubMed ID: 21592863
[TBL] [Abstract][Full Text] [Related]
18. 'Sensing' autoimmunity in type 1 diabetes.
Tsui H; Razavi R; Chan Y; Yantha J; Dosch HM
Trends Mol Med; 2007 Oct; 13(10):405-13. PubMed ID: 17900987
[TBL] [Abstract][Full Text] [Related]
19. Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
Durand CA; Richer MJ; Brenker K; Graves M; Shanina I; Choi K; Horwitz MS; Puri KD; Gold MR
Autoimmunity; 2013 Feb; 46(1):62-73. PubMed ID: 23039284
[TBL] [Abstract][Full Text] [Related]
20. The gut as a regulator of early inflammation in type 1 diabetes.
Vaarala O
Curr Opin Endocrinol Diabetes Obes; 2011 Aug; 18(4):241-7. PubMed ID: 21681088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
